Form4insider filings, from the source

Company · CIK 0001232524 · SIC 2834 — Pharmaceutical Preparations · Nasdaq

Jazz Pharmaceuticals plc · JAZZ

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $2.3M · 3net −$2.3M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesAug 28Sep 2Sep 7Sep 12Sep 18Sep 23Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 10, 2026 SForm 4 →Sep 14, 6:38 pm EDTNeena M PatilEVP & Chief Legal Officer1,200$240.94$289,12847,671−2.46%10b5-1
Sep 8, 2026 SForm 4 →Sep 10, 4:33 pm EDTRenee D GalaPresident & CEO2,000$243.03$486,060143,394−1.38%10b5-1
Sep 8, 2026 FForm 4 →Sep 10, 4:33 pm EDTRenee D GalaPresident & CEO1,967$246.81$485,475145,394—10b5-1
Sep 8, 2026 FForm 4 →Sep 10, 4:28 pm EDTMary Elizabeth HendersonSVP, Technical Operations1,427$243.01$346,77623,815—
Sep 1, 2026 SForm 4 →Sep 2, 5:03 pm EDTBruce C CozaddDirector6,000$250.13$1,500,780351,875−1.68%10b5-1
Aug 31, 2026 FForm 4 →Sep 2, 5:38 pm EDTMary Elizabeth HendersonSVP, Technical Operations2,092$241.41$505,04025,242—
Aug 31, 2026 FForm 4 →Sep 2, 5:34 pm EDTMark Douglas SmithDirector1,706$241.42$411,8579,579—
Aug 31, 2026 FForm 4 →Sep 2, 5:31 pm EDTNorbert G RiedelDirector1,706$241.42$411,8576,923—
Aug 31, 2026 FForm 4 →Sep 2, 5:28 pm EDTTed W LoveDirector743$241.41$179,3692,389—
Aug 31, 2026 FForm 4 →Sep 2, 5:24 pm EDTLaura HamillDirector1,706$241.41$411,8496,832—
Aug 31, 2026 FForm 4 →Sep 2, 5:20 pm EDTJennifer E. CookDirector1,706$241.41$411,84910,736—
Aug 31, 2026 FForm 4 →Sep 2, 5:17 pm EDTPatrick G EnrightDirector1,706$241.42$411,85721,278—
Aug 31, 2026 FForm 4 →Sep 2, 5:13 pm EDTHeather Ann McSharryDirector1,855$241.42$447,82718,199—
Aug 31, 2026 FForm 4 →Sep 2, 5:09 pm EDTPatrick KennedyDirector1,855$241.41$447,8196,452—
Aug 31, 2026 FForm 4 →Sep 2, 5:06 pm EDTRick E WinninghamDirector1,706$241.42$411,8579,466—
Aug 31, 2026 FForm 4 →Sep 2, 5:03 pm EDTBruce C CozaddDirector1,219$241.41$294,281357,875—10b5-1

Reported at this company — derivatives (options, RSUs, warrants)

No reported derivative activity in this period.